Marquette Asset Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87K Hold
30
﹤0.01% 525
2026
Q1
$2.89K Hold
30
﹤0.01% 452
2025
Q4
$2.92K Buy
30
+6
+25% +$515 ﹤0.01% 416
2025
Q3
$1.71K Buy
+24
New +$1.6K ﹤0.01% 588

Other funds holding IRMD

Marquette Asset Management's IRMD Position: Q2 2026 in Review

Marquette Asset Management held its iRadimed (IRMD) position steady in Q2 2026 at 30 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Marquette Asset Management first reported a position in IRMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.92K in Q4 2025. 22 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Marquette Asset Management held 30 shares of iRadimed worth $2.87K as of Q2 2026.
  • Marquette Asset Management left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #525 holding.
  • Marquette Asset Management first reported a position in iRadimed in Q3 2025 and has held it in 4 quarters since.
  • Marquette Asset Management's iRadimed position peaked at $2.92K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.